In this presentation from the Lymphoma & Myeloma 2017, Dr. Adam D. Cohen discusses the future of multiple myeloma therapy, with a specific focus on BITE immunotherapy, CAR-T, and immune checkpoint inhibitors.
Earn CME credit for a related activity at the following location:
© 2017 Imedex, LLC.
Discover the basics of immuno-oncology and the latest…
Back in hospital again with uncontrollable fevers.…
New and invigorating methods of tackling acute myeloid…
Let us help fight cancer. Share your knowledge.
Latest news, views, insights and trends on cancer treatment, discovery and support